Securities and Exchange Commission
                           Washington, D.C. 20549

                          SCHEDULE 14A INFORMATION

                 Proxy Statement Pursuant to Section 14(A)
                   of the Securities Exchange Act of 1934

                        Filed by the Registrant [ ]
               Filed by a Party other than the Registrant [X]

                         Check the appropriate box:
                       [] Preliminary Proxy Statement
                       [ ] Definitive Proxy Statement
                       [X] Definitive Additional Materials
         [ ] Soliciting Material Pursuant to Section 240.14a-11(c)
                           or Section 240.14a-12

                             Circon Corporation
              (Name of Registrant as Specified in its Charter)

                     United States Surgical Corporation
                  (Name of Person Filing Proxy Statement)

                        ----------------------------

          Payment of Filing Fee (Check the appropriate box):

          [X]  No fee required.

          [ ]  Fee computed on table below per Exchange Act Rules
               14a-6(i)(4) and 0-11.

               (1) Title of each class of securities to which
               transaction applies:  N/A

               (2) Aggregate number of securities to which
               transaction applies: N/A

               (3) Per unit price or other underlying value of
               transaction computed pursuant to Exchange Act Rule
               0-11 (Set forth the amount on which the filing fee
               is calculated and state how it was determined): N/A

               (4) Proposed maximum aggregate value of transaction:
               N/A

               (5) Total fee paid: N/A

          [ ]  Fee previously paid with preliminary materials.

          [ ]  Check box if any part of the fee is offset as
               provided by Exchange Act Rule 0-11(a)(2) and
               identify the filing for which the offsetting fee was
               paid previously.  Identify the previous filing by
               registration statement number, or the Form or
               Schedule and the date of its filing.

               (1) Amount previously paid: 

               (2) Form, Schedule or Registration Statement Number:


               (3) Filing Party: 

               (4) Date Filed: 



      FOR IMMEDIATE RELEASE:  September 16, 1997


 INVESTOR CONTACT:        U.S. SURGICAL HOME PAGE    MEDIA CONTACT:
 Marianne Scipione        http://www.ussurg.com      Steve Rose
 Vice President                                      Director
 Corporate Communications                            Media Relations
 (203) 845-1404                                      (203) 845-1732
 marianne.scipione@ussurg.com                        steve.rose@ussurg.com


                     UNITED STATES SURGICAL CORPORATION
                   FILES SUIT AGAINST CIRCON CORPORATION

                NORWALK, CT. -- United States Surgical Corporation
      (NYSE:USS) said today that it has filed suit against Circon
      Corporation (NASDAQ: CCON) in the Court of Chancery in the
      State of Delaware seeking to enjoin Circon from reappointing
      Richard Auhll, Chairman, President and CEO, to the Circon Board 
      after he is voted out of office at the 1997 Circon Annual Meeting 
      on October 6, 1997.

                USS announced that its amended complaint also is 
      seeking to declare void the Board's appointments earlier this 
      year of George Cloutier and R. Bruce Thompson to the Circon 
      Board and placing both of them in a class that is not up for 
      election this year.

                The lawsuit alleges, among other things,  that by
      taking these actions the Circon Board is determined to ignore
      the results of the stockholder vote and has breached its
      fiduciary duties to the stockholders of Circon for the purpose
      of disenfranchising stockholders and preventing them from
      exercising their fundamental right to vote incumbent management
      off the Board.

                United States Surgical Corporation is a diversified
      surgical products company specializing in minimally invasive
      technologies that improve patient care and lower health costs.